• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症性肠病活动期患者住院期间和出院后的静脉血栓栓塞风险。

The risk of venous thromboembolism during and after hospitalisation in patients with inflammatory bowel disease activity.

机构信息

Division of Epidemiology and Public Health, University of Nottingham, Nottingham, UK.

Nottingham Digestive Diseases Centre Biomedical Research Unit, University of Nottingham, Nottingham, UK.

出版信息

Aliment Pharmacol Ther. 2018 Nov;48(10):1099-1108. doi: 10.1111/apt.15010. Epub 2018 Oct 8.

DOI:10.1111/apt.15010
PMID:30294897
Abstract

BACKGROUND

Inflammatory bowel disease (IBD) increases the risk of venous thromboembolism.

AIMS

To determine when patients are at high risk of thromboembolic events, including after major surgery, and to guide timing of thromboprophylaxis.

METHODS

Each IBD patient from Clinical Practice Research Datalink, linked with Hospital Episode Statistics, was matched to up to five non-IBD patients in this cohort study. We examined their risk of thromboembolism in hospital and within 6 weeks after leaving hospital, with or without undergoing major surgery, and while ambulant. Hazard ratios were estimated using Cox regression, with adjustment for age, sex, body mass index, smoking and history of malignancy or thromboembolism.

RESULTS

Overall 23 046 IBD patients had a thromboembolic risk 1.74-times (95% CI = 1.55-1.96) higher than 106 795 non-IBD patients. Among ambulant patients, the thromboembolic risk was raised during acute (hazard ratio = 3.94, 2.79-5.57) or chronic disease activity (3.97, 2.90-5.45) but their absolute risk remained below 5/1000 person-years. The hazard ratio for thromboembolism among in-patients not undergoing major surgery was 1.13 (0.63-2.02), compared to 2.43 (1.20-4.92) among surgical patients, with a near doubling of absolute risk associated with surgery (59.5/1000 person-years, compared with 31.1 without surgery). The absolute risk remained elevated within 6 weeks after leaving hospital (18.6/1000 person-years in IBD patients after surgery).

CONCLUSIONS

IBD patients are at an increased risk of venous thromboembolism. Absolute risks are raised during active disease, when in hospital, and after leaving hospital following major surgery.

摘要

背景

炎症性肠病(IBD)会增加静脉血栓栓塞的风险。

目的

确定患者发生血栓栓塞事件的高危期,包括在重大手术后,并指导血栓预防的时机。

方法

本队列研究中,从临床实践研究数据库中匹配每个 IBD 患者,与医院发病统计数据相关联。我们检查了他们在医院和出院后 6 周内发生血栓栓塞的风险,无论是否接受重大手术以及是否能走动。使用 Cox 回归估计风险比,并调整年龄、性别、体重指数、吸烟状况以及恶性肿瘤或血栓栓塞史。

结果

总体而言,23046 例 IBD 患者的血栓栓塞风险比 106795 例非 IBD 患者高 1.74 倍(95%CI=1.55-1.96)。在能走动的患者中,急性(风险比=3.94,2.79-5.57)或慢性疾病活动期(3.97,2.90-5.45)时血栓栓塞风险增加,但绝对风险仍低于 5/1000 人年。未接受重大手术的住院患者发生血栓栓塞的风险比为 1.13(0.63-2.02),而手术患者为 2.43(1.20-4.92),手术相关的绝对风险增加近一倍(59.5/1000 人年,而无手术者为 31.1/1000 人年)。出院后 6 周内,绝对风险仍然升高(手术患者出院后 IBD 患者为 18.6/1000 人年)。

结论

IBD 患者发生静脉血栓栓塞的风险增加。在疾病活动期、住院期间和重大手术后出院后,绝对风险增加。

相似文献

1
The risk of venous thromboembolism during and after hospitalisation in patients with inflammatory bowel disease activity.炎症性肠病活动期患者住院期间和出院后的静脉血栓栓塞风险。
Aliment Pharmacol Ther. 2018 Nov;48(10):1099-1108. doi: 10.1111/apt.15010. Epub 2018 Oct 8.
2
Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study.炎症性肠病活动期和缓解期的静脉血栓栓塞症:一项队列研究。
Lancet. 2010 Feb 20;375(9715):657-63. doi: 10.1016/S0140-6736(09)61963-2. Epub 2010 Feb 8.
3
Venous Thromboembolism Risk in Asian Patients with Inflammatory Bowel Disease: A Population-Based Nationwide Inception Cohort Study.亚洲炎症性肠病患者的静脉血栓栓塞风险:一项基于人群的全国性发病队列研究。
Gut Liver. 2022 Jul 15;16(4):555-566. doi: 10.5009/gnl210190. Epub 2021 Nov 18.
4
Inflammatory bowel disease and venous thromboembolism during pregnancy and the postpartum period.妊娠和产后期间的炎症性肠病和静脉血栓栓塞症。
J Thromb Haemost. 2017 Apr;15(4):702-708. doi: 10.1111/jth.13638. Epub 2017 Feb 24.
5
Postoperative Venous Thromboembolism in Patients Undergoing Abdominal Surgery for IBD: A Common but Rarely Addressed Problem.接受腹部手术治疗炎症性肠病患者的术后静脉血栓栓塞:一个常见但很少被提及的问题。
Dis Colon Rectum. 2017 Jan;60(1):61-67. doi: 10.1097/DCR.0000000000000721.
6
Extended Venous Thromboembolism Prophylaxis After Elective Surgery for IBD Patients: Nomogram-Based Risk Assessment and Prediction from Nationwide Cohort.择期手术治疗炎症性肠病患者的静脉血栓栓塞症延伸预防:基于列线图的全国性队列风险评估和预测。
Dis Colon Rectum. 2018 Oct;61(10):1170-1179. doi: 10.1097/DCR.0000000000001189.
7
Clinical presentation of venous thromboembolism in inflammatory bowel disease.炎症性肠病相关静脉血栓栓塞症的临床表现。
J Crohns Colitis. 2013 Oct;7(9):723-9. doi: 10.1016/j.crohns.2012.10.008. Epub 2012 Nov 3.
8
Thromboprophylaxis is associated with reduced post-hospitalization venous thromboembolic events in patients with inflammatory bowel diseases.血栓预防与炎症性肠病患者住院后静脉血栓栓塞事件的减少有关。
Clin Gastroenterol Hepatol. 2014 Nov;12(11):1905-10. doi: 10.1016/j.cgh.2014.02.034. Epub 2014 Mar 12.
9
Unawareness of thromboprophylaxis is associated with low venous thromboembolism occurrence in hospitalized patients with acute inflammatory bowel disease flare.住院的急性炎症性肠病发作患者对血栓预防的认识不足与静脉血栓栓塞症发生率低有关。
Minerva Med. 2020 Dec;111(6):560-565. doi: 10.23736/S0026-4806.20.06885-8. Epub 2020 Jul 28.
10
Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism.炎症性肠病是复发性静脉血栓栓塞的一个危险因素。
Gastroenterology. 2010 Sep;139(3):779-87, 787.e1. doi: 10.1053/j.gastro.2010.05.026. Epub 2010 Jun 12.

引用本文的文献

1
Preoperative Optimization of Crohn's Patients before Abdominopelvic Surgery.克罗恩病患者腹部盆腔手术前的术前优化
Clin Colon Rectal Surg. 2024 Apr 25;38(2):85-95. doi: 10.1055/s-0044-1786380. eCollection 2025 Mar.
2
Controversies in Venous Thromboembolism Risk Assessment in Inflammatory Bowel Disease: A Narrative Review.炎症性肠病静脉血栓栓塞风险评估中的争议:一项叙述性综述
Diagnostics (Basel). 2024 Sep 24;14(19):2112. doi: 10.3390/diagnostics14192112.
3
Finding the Balance: Venous Thromboembolism Prophylaxis during Hematochezia in Crohn's Disease.
寻找平衡:克罗恩病便血期间的静脉血栓栓塞预防
Case Rep Gastroenterol. 2024 Jul 22;18(1):367-372. doi: 10.1159/000540128. eCollection 2024 Jan-Dec.
4
Peri-Operative Optimization of Patients with Crohn's Disease.克罗恩病围手术期患者的优化处理。
Curr Gastroenterol Rep. 2024 May;26(5):125-136. doi: 10.1007/s11894-024-00925-9. Epub 2024 Feb 29.
5
Standard and Extended Thromboprophylaxis in Patients with Inflammatory Bowel Disease: A Literature Review.炎症性肠病患者的标准和延长血栓预防:文献综述
Euroasian J Hepatogastroenterol. 2023 Jul-Dec;13(2):133-141. doi: 10.5005/jp-journals-10018-1401.
6
Anti-tumor Necrosis Factor Alpha Versus Corticosteroids: A 3-fold Difference in the Occurrence of Venous Thromboembolism in Inflammatory Bowel Disease-A Systematic Review and Meta-analysis.抗肿瘤坏死因子 α 与皮质类固醇:炎症性肠病静脉血栓栓塞发生率的 3 倍差异-系统评价和荟萃分析。
J Crohns Colitis. 2024 May 31;18(5):773-783. doi: 10.1093/ecco-jcc/jjad193.
7
Inflammatory Bowel Disease Therapy and Venous Thromboembolism.炎症性肠病治疗与静脉血栓栓塞症
Curr Treat Options Gastroenterol. 2020 Sep;18(3):462-475. doi: 10.1007/s11938-020-00304-z. Epub 2020 Aug 4.
8
Venous Thromboembolism Risk in Asian Patients with Inflammatory Bowel Disease: A Population-Based Nationwide Inception Cohort Study.亚洲炎症性肠病患者的静脉血栓栓塞风险:一项基于人群的全国性发病队列研究。
Gut Liver. 2022 Jul 15;16(4):555-566. doi: 10.5009/gnl210190. Epub 2021 Nov 18.
9
Cost-effectiveness of Venous Thromboembolism Prophylaxis After Hospitalization in Patients With Inflammatory Bowel Disease.炎症性肠病患者住院后静脉血栓栓塞预防的成本效益。
Inflamm Bowel Dis. 2022 Aug 1;28(8):1169-1176. doi: 10.1093/ibd/izab246.
10
The risk of venous thromboembolic events in patients with inflammatory bowel disease: a systematic review and meta-analysis.炎症性肠病患者发生静脉血栓栓塞事件的风险:一项系统评价和荟萃分析。
Ann Gastroenterol. 2021 Sep-Oct;34(5):680-690. doi: 10.20524/aog.2021.0631. Epub 2021 May 27.